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Quarantine and Isolation
Interim Guidance for Ships on Managing Suspected
Coronavirus Disease 2019
Early detection, prevention, and control of Coronavirus Disease 2019 (COVID-19) on ships is important to protect the
health of travelers on ships and to avoid transmission of the virus by disembarking passengers and crew members who
are suspected of having COVID-19.
The latest situation summary updates are available on CDC’s web page Coronavirus Disease 2019.
Purpose
This document provides guidance for ships originating from, or stopping in, the United States to help prevent, detect, and
medically manage suspected COVID-19 infections. As ships travel worldwide, ship management and medical staff need to
be aware and respond to local jurisdictional requirements.
A patient’s travel and exposure history, clinical presentation, and underlying medical conditions are essential in the
assessment and decision-making process for patients who may need for further medical evaluation, testing, and
treatment.
This document provides guidance for preventing spread of COVID-19 during and after a voyage, including personal
protective measures for crew members.
CDC will update this interim guidance to ships as needed and as additional information becomes available.
Reducing the spread
Commercial shipping, including cruise ships and other passenger vessels, involves the movement of large numbers of
people in closed and semi-closed settings. Like other close-contact environments, ships may  facilitate transmission of
respiratory viruses from person to person through exposure to respiratory droplets or contact with contaminated
surfaces.
To reduce spread of respiratory infections including COVID-19, CDC recommends that ships encourage crew members
and passengers to
Summary of Recent Changes
Revisions were made on February 18, 2020 to reflect the following:
Clarified guidance on laundry and disposal of used PPE and other disposable items.
Postpone travel when sick
Watch their health
Self-isolate and inform the onboard medical center immediately if they develop a fever (100.4 F / 38 C or higher),
begin to feel feverish, or develop other signs or symptoms of sickness
Use respiratory, cough, and hand hygiene
Advise passengers and crew of the importance of covering coughs and sneezes with a tissue. Dispose used
tissues immediately in a disposable container (e.g., plastic bag) or a washable trash can.
Remind passengers and crew members to wash their hands often with soap and water, especially after
coughing or sneezing. If soap and water are not available, they can use a hand sanitizer containing 60%-95%
alcohol).
Clinical evaluation of suspect cases
Identifying and isolating passengers and crew with possible symptoms of COVID-19 as soon as possible is needed to
minimize transmission of this virus. Cruise ship medical personnel and telemedicine providers should reference CDC’s
COVID-19 website Information Healthcare Professionals for the latest information on infection control, clinical
management, collecting clinical specimens, and evaluating patients who may be sick with or who have been exposed to
COVID-19.
Symptoms may include fever, cough, and shortness of breath. Patients have a fever if they feel warm to the touch, give a
history of feeling feverish, or have a measured temperature of 100.4°F (38°C) or higher. COVID-19 infections have ranged
from little-to-no symptoms to severe illness and death. The incubation period is believed to be 2–14 days. Cruise ship
medical staff and telemedicine providers evaluating patients with fever or acute respiratory illness should obtain a
detailed travel history and assess for any other potential exposures to a person with confirmed COVID-19 infection.
Although routes of transmission have yet to be definitively determined, CDC recommends a cautious approach to
interacting with patients under investigation.
Ask such patients to wear a facemask (a surgical mask, not N-95) as soon as they are identified.
Evaluate patients in a private room with the door closed, ideally an airborne infection isolation room, if available.
Staff entering the room should use Standard Precautions, Contact Precautions, and Airborne Precautions, and use
eye protection (such as goggles or a face shield).
Because the signs and symptoms of COVID-19 are non-specific, people onboard who have fever or acute respiratory
illness should be tested for influenza. CDC’s influenza website also includes recommendations for the clinical use of
influenza diagnostic tests, information on available tests, specimen collection, and guidance on interpreting
influenza testing results. CDC has published Guidance for Cruise Ships on Influenza-like Illness (ILI) Management
Managing sick passengers or crew when boarding and
onboard
Deny boarding of a passenger or crew member who is suspected to have COVID-19 infection based on signs and
symptoms plus travel history in China or other known exposure at the time of embarkation.
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Isolate passengers or crew onboard who are suspected of having COVID-19 infection in a single-occupancy cabin with the
door closed until symptoms are improved. Discontinuing isolation precautions is made on a case-by-case basis, in
consultation with CDC.
Ideally, medical follow-up should occur in the isolated person’s cabin. Coordinate visits to the onboard medical center in
advance, if needed, with medical staff. Have the sick person wear a facemask before leaving their cabin.
Managing passengers and crew after exposure
Refer to CDC guidance for information about assessing exposure risk and recommended public health management. CDC
is available for consultation on risk assessment and management of exposed passengers and crew. For consultation,
contact the CDC Emergency Operations Center at 770-488-7100 or eocreport@cdc.gov.
Passengers and crew members who have had high-risk exposures to a person suspected of having COVID-19 should be
quarantined in their cabins. All potentially exposed passengers, cruise ship medical staff, and crew members should self-
monitor under supervision of ship medical staff or telemedicine providers until 14 days after the last possible exposure.
Preventing infection in crew members
Ensure your crew members are aware of the
Global risk of COVID-19 during international travel
Signs and symptoms that may indicate a sick traveler has COVID-19
Requirement for the ship’s medical unit to report a traveler with suspected or known COVID-19 to CDC, if ship is
destined for a US port
Importance of not working on a ship while sick with fever or acute respiratory symptoms
The ship’s company should also review their sick leave polices and communicate them to employees.
CDC recommends that crew members who self-report or appear to have fever or acute respiratory symptoms (such as
cough or shortness of breath) be immediately evaluated.
In addition to annual influenza vaccination, have crew members follow these recommendations when their work activities
involve contact with passengers and other crew members who have fever or acute respiratory illness.
Ask the sick person to wear a facemask if tolerated, any time they leave their cabin or interact with other people
Maintain a distance of 6 feet from the sick person while interviewing, escorting, or providing other assistance.
Keep interactions with sick people as brief as possible.
Limit the number of people who interact with sick people. To the extent possible, have a single person give care and
meals to the sick person.
Avoid touching your eyes, nose, and mouth.
Wash your hands often with soap and water. If soap and water are not available and if hands are not visibly soiled,
use a hand sanitizer containing 60%-95% alcohol.
Provide tissues and access to soap and water and ask the sick persons to:
Cover their mouth and nose with a tissue (or facemask) when coughing or sneezing.
Throw away used tissues immediately in a disposable container (e.g., plastic bag) or a washable trash can.
Wash their hands often with soap and water for 20 seconds. If soap and water are not available and hands are
not visibly soiled, the sick person should use a hand sanitizer containing 60%-95% alcohol.
If soap and water are not available and hands are not visibly soiled, the sick person should use a hand sanitizer
containing 60%-95% alcohol.
Personal protective equipment and instructions for crew members
Instruct crew members and other staff who may have contact with people with symptoms of COVID-19 in the proper
use, storage, and disposal of personal protective equipment (PPE). Wrong use or handling of PPE can increase the
spread of disease.
Wear impermeable, disposable gloves if crew members need to have direct contact with sick people or potentially
contaminated surfaces, rooms, or lavatories used by sick passengers and crew members. Instruct crew members to
wash their hands with soap and water or use an alcohol-based hand sanitizer after removing gloves. Discard used
gloves in the trash and don’t wash or save for reuse. Avoid touching their faces with gloved or unwashed hands.
Wearing N-95 respirators or face masks is not generally recommended for cruise ship crew members for general
work activities. Wearing face masks can be considered for cruise ship workers who can’t avoid close contact with
people who have fever, cough, or difficulty breathing. Crew members need annual fit testing to wear N-95
respirators.
Reporting
CDC requires that ships destined for a US port of entry immediately report any death onboard or illness that meets CDC’s
definition of “ill person,” including suspected cases of COVID-19, to the CDC Quarantine Station with jurisdiction for the
port.
Additional information for non-cruise ships: : If the signs and symptoms are consistent with CDC’s standard
required reporting requirements, please have the following information available before notifying the nearest CDC
Quarantine Station:
List of the sick traveler’s signs and symptoms, including onset dates
The sick traveler’s highest recorded temperature
The sick traveler’s embarkation date and port
The ship’s ports of call during the 14 days before the person got sick
List of ports of call where the sick traveler disembarked during the 14 days before the person got sick
For ships on international voyages, if an illness occurred on board, complete the Maritime Declaration of Health and send
to the competent authority, according to the 2005 International Health Regulations and the national legislation of the
country of disembarkation.
Consultation
To consult CDC about assessing exposure risk and identifying contacts of ill travelers and crew, clinical management,
laboratory specimen collection, or infection control concerns related to COVID-19, contact the CDC Emergency
Operations Center at 770-488-7100 or eocreport@cdc.gov.
Managing passengers or crew upon disembarkation
Before arriving at a US port, vessel medical staff and telemedicine providers or a cruise line representative must discuss
the disembarkation of patients suspected of having COVID-19 with the CDC Quarantine Station having jurisdiction for the
port and with the state and local health departments. CDC quarantine officials can help communicate with state and local
health departments and will work with the ship’s company, port partners, and health departments to ensure safe
disembarkation and medical transportation of the patient upon arrival.
Additional recommendations
Personal protective equipment
Instruct crew members and other staff who may have contact with persons suspected of having COVID-19 in the proper
storage, use (including safe donning and doffing [PDF – 3 pages]), and disposal of PPE. Wrong use or handling of PPE
can increase spread of disease.
Ship supplies
Ships should ensure availability of conveniently located dispensers of alcohol-based hand sanitizer. Where sinks are
available, ensure handwashing supplies (such as soap, disposable towels) are consistently available.
Ships should carry a sufficient quantity of
PPE, including facemasks, NIOSH-certified disposable N95 filtering facepiece respirators, eye protection such as
goggles or disposable face shields that cover the front and sides of the face, and disposable medical gloves and
gowns.
medical supplies to meet day-to-day needs. Have contingency plans for rapid resupply during outbreaks.
sterile viral transport media and sterile swabs to collect nasopharyngeal and nasal specimens if COVID-19 infection
is suspected.
These optimal recommendations can be modified to reflect individual ship capabilities and characteristics.
Cleaning and Disinfection
At this time, in addition to routine cleaning and disinfection strategies, ships may consider more frequent cleaning of
commonly touched surfaces such as handrails, countertops, and doorknobs. The primary mode of COVID-19 virus
transmission is believed to be through respiratory droplets that are spread from an infected person through coughing or
sneezing to a susceptible close contact within about 6 feet. Therefore, widespread disinfection is unlikely to be effective.
Cleaning when COVID-19 is suspected
Cleaning recommendations are based on existing CDC infection control guidance for preventing COVID-19 from
spreading to others in homes.
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Standard practice for pathogens spread by air (such as measles, tuberculosis) is to restrict people unprotected (for
example, no respiratory protection) from entering a vacated room until sufficient time has elapsed for enough air
changes to remove potentially infectious particles (more information on clearance rates under differing ventilation
conditions is available).
We don’t yet know how long COVID-19 remains infectious in the air.
In the interim, it is reasonable to apply a similar time period before entering the sick person’s room without respiratory
protection as used for other pathogens spread by air (for example, measles, tuberculosis). Using measles as the example 
[PDF – 13 pages], restrict access for two hours after the sick person has left the room.
Clean surfaces infected by the respiratory secretions of a sick person suspected with COVID-19 (for example, in the sick
person’s living quarters or work area, and in isolation rooms).
Use disinfectant products against COVID-19 with Environmental Protection Agency (EPA)-approved emerging viral
pathogens claims. These products can be identified by the following claim:
[Product name] has demonstrated effectiveness against viruses similar to COVID-19 on hard non-porous surfaces.
Therefore, this product can be used against COVID-19 when used in accordance with the directions for use against
[name of supporting virus] on hard, non-porous surfaces.
Specific claims for “COVID-19” will not appear on the product or master label.
More information about EPA-approved emerging viral pathogens claims can be found here .
If there are no available EPA-registered products with an approved emerging viral pathogen claim for COVID-
19, use products with label claims against human coronaviruses according to label instructions.
This claim or a similar claim, will be made only through the following communications outlets: technical literature
distributed exclusively to healthcare facilities, physicians, nurses, and public health officials, “1-800” consumer
information services, social media sites and company websites (non-label related).
In addition to wearing disposable gloves during routine cleaning, wear disposable gowns when cleaning areas suspected
to be contaminated by COVID-19. Wear PPE compatible with the disinfectant products being used and approved for use
onboard the ship. Remove carefully [PDF – 1 page] gloves and gowns to avoid cross-contamination and the
surrounding area.
Perform hand hygiene upon removing and disposing gloves by washing hands often with soap and water for at least 20
seconds or using an alcohol-based hand sanitizer that contains 60 to 95% alcohol.
Clean all “high-touch” surfaces in the sick person’s room (for example, counters, tabletops, doorknobs, light switches,
bathroom fixtures, toilets, phones, keyboards, tablets, and bedside tables) according to instructions described for the
above EPA-registered product. Wear disposable gloves and gowns during cleaning activities.
If visible contamination (for example, blood, respiratory secretions, or other body fluids) is present, the basic principles
for blood or body substance spill management are outlined in the United States Occupational Safety and Health
Administration (OSHA) Bloodborne Pathogen Standard . CDC guidelines recommend removing bulk spill matter,
cleaning the site, and then disinfecting the site with the above EPA-registered disinfectant. For soft (porous) surfaces such
as carpeted floor, rugs, and drapes, remove visible contamination if present, and wash according to the manufacturer’s
instructions. Clean and disinfect unremovable materials with products mentioned above and allow to air dry.
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When cleaning is completed, collect soiled textiles and linens in sturdy leak-proof containers; these can be laundered
using conventional processes following your standard operating procedures. PPE should be removed and placed with
other disposable items in sturdy, leak-proof (plastic) bags that are tied shut and not reopened. The bags of used PPE and
disposable items can then be placed into the solid waste stream according to routine procedures. Follow your standard
operating procedures for waste removal and treatment.
No additional cleaning is needed for the ship’s supply-and-return ventilation registers or filtration systems.
No additional treatment of wastewater is needed.
Summary of Past Changes
Revisions were made on February 13, 2020 to reflect the following:
Updated guidance title to include “Suspected”
Updated 2019-nCoV to “Coronavirus Disease 2019 (COVID-19)”
Updated guidance on managing sick passengers or crew when boarding and onboard to isolate passengers or
crew onboard who are suspected of having COVID-19.
Updated guidance on preventing infection in crew members to include asking the sick person to wear a facemask
if tolerated, any time they leave their cabin or interact with other people.
Updated guidance on additional items to report for non-cruise ships.
Page last reviewed: February 18, 2020
